177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer.
about
177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@en
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@nl
type
label
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@en
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@nl
prefLabel
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@en
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
177Lu-PSMA-617 radioligand the ...... de metastatic prostate cancer.
@en
P2093
Christian Uprimny
Finn E von Eyben
Irene Virgolini
Kalevi Kairemo
Timo Kiljunen
P2860
P304
66112-66116
P356
10.18632/ONCOTARGET.19805
P407
P50
P577
2017-08-02T00:00:00Z